Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, January 2011

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 32 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 363 followers.

[VEGF] Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in fir... http://t.co/3B7DO0m5 PM

Reply Repost Favourite